share_log

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update

SEC announcement ·  Feb 14 07:37
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more